$13/unit

Jeuveau is another injectable product containing the same active ingredient as Botox, which is botulinum toxin. It received FDA approval in the United States in 2019. Its intended use is quite similar to what you might already be familiar with, as it aims to reduce the visibility of frown lines. Sometimes nicknamed "Newtox," Jeuveau represents the latest addition to the wrinkle-relaxing market. Many individuals describe a 'softening' effect not typically associated with Botox. What sets Jeuveau apart is its quicker onset compared to Botox and Dysport, taking effect in just 2-5 days.